OwieClear Chronic Kidney Disease Page Accuracy Review
An independent accuracy review of our chronic kidney disease page, finding no major factual errors and suggesting a stage and albuminuria map, bone and potassium one-liners, and clearer nephrology referral cues.
Submitted research brief - Submitted to OwieClear; written with an AI assistant - November 2026
Read this first. This document was written outside OwieClear and has not been reviewed by a clinician. We publish it so you can read the source for yourself. It is educational and is not medical advice. Where our own pages disagree with it, follow our pages, which cite their sources, and ask a healthcare professional about anything that affects your care.
What we found that needs correcting
- This review was commissioned as a check on our own work and we are publishing it unedited. It rated the page one of the stronger chronic-disease pages on the site with no major factual errors, and made five optional suggestions. We have acted on all five in update 299, and the notes below record what changed.
- On the first point, a plain-language stage map. The page now carries the five eGFR stages with their boundaries, the three albuminuria categories A1 to A3, and the explanation that the two combine into a risk picture. A full deep dive covers the grid, and makes the point the review implies: a stage without an albuminuria category is half an answer.
- On the second, bone and mineral disease. CKD mineral and bone disorder and secondary hyperparathyroidism are now in the complications list, with a deep dive explaining the mechanism, that failing kidneys cannot activate vitamin D or clear phosphate, and that the calcium released from bone deposits in blood vessels.
- On the third, hyperkalemia. The page now states that high potassium can be dangerous, that it is usually silent until severe, and that potassium-based salt substitutes should not be started without asking. This last point has its own deep dive, because the advice to cut salt and the advice to avoid potassium substitutes are routinely given separately, and a reader who follows only the first can come to harm.
- On the fourth, nephrology referral. The page now lists the common triggers: eGFR persistently below 30, a sustained decline of more than about 5 per year, albuminuria above 300 mg/g, persistent unexplained blood in the urine with protein, and hypertension resistant to four or more medicines. A deep dive explains why early referral matters, chiefly because fistula creation and transplant workup both take months.
- On the fifth, race and ethnicity. We have kept the higher rates in the listed groups as stated fact and added the explanation that this reflects how risk, food environments and access to care are distributed, alongside APOL1 gene variants in some people, rather than race being a biological cause in itself. We have also added the 2021 move to a race-free eGFR equation, since the previous adjustment delayed diagnosis, referral and transplant listing for Black patients, and that is the most consequential part of this topic for a reader.
- The suggested symptom framing has been adopted: early CKD usually has no symptoms and is found on tests; as it advances, foamy urine, swelling, fatigue and nocturia; in more advanced disease, itch, cramps, nausea, poor appetite, difficulty concentrating and reduced urine output.
- Two additions of our own, beyond the review's scope. The expected fall in eGFR of up to around 30 percent after starting an ACE inhibitor, ARB or SGLT2 inhibitor is now stated plainly, because people stop effective medicines over it. And sick-day rules, naming which medicines are paused during illness with vomiting or dehydration, are now on the page.
- We have also added sixteen research deep dives covering kidney physiology, the hyperfiltration cycle, eGFR and urine albumin testing, causes, kidney-protective and kidney-harmful medicines, dialysis and transplant, nutrition, potassium and phosphorus, anaemia and bone disease, referral and prevention.
Download the PDF
Our reviewed pages on this
All source documents